Our findings suggest that obesity-driven factors such as HGF/c-Met, insulin, and the leptin:adiponectin ratio may contribute to the onset of obesity-promoted BBCs, and that weight loss prior to tumor onset may prevent tumor progression. Here, MET is linked to obesity disorder.